Form 8-K - Current report:
SEC Accession No. 0001490978-25-000013
Filing Date
2025-02-26
Accepted
2025-02-26 16:07:20
Documents
14
Period of Report
2025-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sdgr-20250226.htm   iXBRL 8-K 27377
2 EX-99.1 sdgr-20241231xexx991.htm EX-99.1 267699
  Complete submission text file 0001490978-25-000013.txt   445403

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sdgr-20250226.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sdgr-20250226_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sdgr-20250226_pre.xml EX-101.PRE 13054
17 EXTRACTED XBRL INSTANCE DOCUMENT sdgr-20250226_htm.xml XML 3223
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 25670011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)